It is noteworthy that Kir4.1 protein levels are also under the control of Methyl-CpG-binding protein 2 (MeCP2), a transcriptional regulator expressed in both neurons and glial cells46, and whose mutations lead to 95% of Rett syndrome cases47. The gene discussed is MECP2; the disease is atypical Rett syndrome.